156 related articles for article (PubMed ID: 32957374)
1. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):103-110. PubMed ID: 32044878
[TBL] [Abstract][Full Text] [Related]
3. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Li J; Yang Z; Huang S; Li D
Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
[TBL] [Abstract][Full Text] [Related]
4. Expression of Lamininγ2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(5):2099-102. PubMed ID: 25773857
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
[TBL] [Abstract][Full Text] [Related]
6. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T
Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Biomark Med; 2020 Nov; 14(16):1573-1584. PubMed ID: 32960074
[No Abstract] [Full Text] [Related]
9. Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis.
He J; Yang Z; Wu Z; Wang L; Xu S; Zou Q; Yuan Y; Li D
Onco Targets Ther; 2019; 12():2955-2965. PubMed ID: 31114239
[No Abstract] [Full Text] [Related]
10. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
[TBL] [Abstract][Full Text] [Related]
11. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
12. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
[TBL] [Abstract][Full Text] [Related]
13. Potentials of CCL21 and CBS as Therapeutic Approaches for Breast Cancer.
Peng J; Zhang D
Eur Surg Res; 2022; 63(4):211-223. PubMed ID: 35026764
[TBL] [Abstract][Full Text] [Related]
14. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Paraaortic Lymph Node Metastasis in Extrahepatic Cholangiocarcinoma.
Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Otsuka S; Sasaki K; Uesaka K
World J Surg; 2021 Feb; 45(2):581-589. PubMed ID: 33079246
[TBL] [Abstract][Full Text] [Related]
16. The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Am J Med Sci; 2022 Aug; 364(2):181-191. PubMed ID: 34800429
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.
Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C
Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466
[TBL] [Abstract][Full Text] [Related]
19. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
[TBL] [Abstract][Full Text] [Related]
20. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
